Perimenopause and Insulin Resistance: Why the Same Habits Stopped Working (2026)
You didn't change anything. Same breakfast, same walk, same portions you've eaten for a decade. And somewhere around 44, your body started keeping score differently.
Perimenopause is associated with rising insulin resistance, meaning your cells respond less efficiently to insulin and your body compensates by producing more of it. Human studies link this shift to declining estrogen, fat redistributing toward the abdomen, and disrupted sleep. Higher circulating insulin is associated with stronger appetite signals.
That's the short version. The longer version is more interesting, and a lot less fatalistic.
Key takeaways
- Insulin resistance often climbs before periods stop.
- Fat moves to the middle, independent of scale weight.
- Short sleep alone measurably impairs insulin signaling.
- Muscle is the largest place glucose goes.
- Cravings track hormones, not character.
What is insulin resistance, in plain language?
Insulin is the hormone that tells your cells to take glucose out of your blood and use it or store it. Insulin resistance means those cells have gotten less responsive to that message.
Your pancreas notices and compensates. It sends more insulin. Blood sugar can look completely normal on a standard lab panel for years while insulin quietly runs higher and higher in the background.
That's why so many women in their forties get told everything looks fine. Fasting glucose is a late signal. Fasting insulin is an earlier one, and most routine panels don't measure it.
Researchers usually estimate insulin resistance with HOMA-IR, a calculation using fasting glucose and fasting insulin together. A 2023 study of 252 perimenopausal women in Poland found HOMA-IR correlated strongly with fasting glucose (r = 0.72) and HbA1c (r = 0.74), and that several simple lipid-based indices also tracked metabolic risk in this group (Cybulska et al., 2023).
Why does perimenopause change insulin sensitivity?
Three things happen at once, and they feed each other.
1. Estrogen stops being steady. Perimenopause runs as a decade of erratic peaks and crashes, not a tidy downward slope. A review in Climacteric concluded that while menopause itself doesn't independently cause weight gain, the hormonal shift is associated with increased total body fat and increased abdominal fat, and that estrogen therapy partly blunts that redistribution (Davis et al., 2012).
2. Fat relocates. Visceral fat, the kind packed around your organs, becomes metabolically noisy. It releases inflammatory signals that make insulin work less well. In the SWAN fat patterning study, 359 midlife women had CT-measured visceral fat, and bioavailable testosterone predicted it independently of age, race, total body fat, and even insulin resistance itself (Janssen et al., 2009).
3. Sleep falls apart. Night sweats, 3am wake-ups, and the general 2am staring contest with the ceiling are not a side plot here. They're part of the mechanism.
Your cravings aren't really a willpower problem. They're a hormone problem.
Is it menopause or is it just aging?
Fair question, and researchers have argued about it for twenty years.
The current read is that both are happening, and they're separable. A review of longitudinal data concluded that menopause-related factors, including earlier age at menopause and surgical menopause, are associated with worse cardiovascular outcomes beyond what chronological aging explains, along with unfavorable changes in body composition, visceral fat, lipids, and metabolic syndrome risk (El Khoudary and Nasr, 2022).
A separate clinical review put it more bluntly: the menopausal transition is associated with central fat accumulation, lower energy expenditure, weight gain, insulin resistance, and a pro-atherogenic lipid profile (Lambrinoudaki and Armeni, 2023).
So the honest answer is: aging is doing some of this. The transition is doing the rest. And the transition part is the part that arrives fast enough to feel like something broke overnight.
How does insulin resistance turn into cravings?
This is the part nobody explains at the annual physical.
When insulin runs high, it pushes glucose out of the blood aggressively. You get a faster drop after meals. That drop reads to your brain as a fuel emergency, and a fuel emergency reads as hunger, usually specifically for fast carbohydrate.
So you eat a sensible dinner at 7 and by 9:30 you're hungry in a way that has nothing to do with your stomach being empty. Our customers describe it constantly. One wrote in a survey: "I binge eat in the evenings all the way up to bedtime!! I'm not hungry, I know this."
Add poor sleep and it compounds. Higher inflammation also seems to be in the mix: in 151 perimenopausal and early postmenopausal women, higher baseline interleukin-6 predicted a 12-month increase in HOMA-IR and in the number of metabolic syndrome criteria met (Zannas et al., 2020).
If any of this sounds like the mental loop you've been fighting, our guide to what food noise actually is covers the appetite side in more detail, and hormonal hunger vs real hunger covers how to tell them apart in the moment.
What does the research actually show about sleep?
Sleep gets treated as the soft, optional lever. It isn't.
In a randomized crossover study at the University of Chicago, seven healthy young adults spent four nights at 4.5 hours in bed and four nights at 8.5 hours, with food and activity controlled. Researchers then biopsied subcutaneous fat and tested how the fat cells responded to insulin directly.
After the short-sleep condition, the insulin concentration needed for a half-maximal signaling response was nearly 3 times higher, and whole-body insulin sensitivity dropped in parallel (Broussard et al., 2012).
That's a small study in young adults, not perimenopausal women, so don't over-read the number. But the direction is about as clean as human metabolic research gets. Four nights. Healthy people. Measurable resistance at the cell level.
Which means the night sweats waking you at 3am aren't just unpleasant. They're metabolically expensive.
What the research has actually studied
A note on evidence quality, because this category is full of overreach.
Some of the studies below were run in people already diagnosed with metabolic syndrome or type 2 diabetes, under medical supervision. Those findings tell you something about mechanism. They don't tell you what a supplement will do for a healthy 47-year-old, and we're not going to pretend otherwise.
| Lever | What was studied | Population | Strength |
|---|---|---|---|
| Sleep duration | 4 nights of 4.5h vs 8.5h in bed, fat-cell insulin signaling | 7 healthy adults | Strong mechanism, tiny sample |
| Resistance training | 13 months high-intensity vs low-intensity control | 54 early postmenopausal women | Lean mass and abdominal fat improved; metabolic score did not differ |
| Structured exercise | 8 weeks resistance or interval training | 45 postmenopausal women with metabolic syndrome | Diagnosed population, under supervision |
| Allulose with a sugar load | Dose-dependent lower postprandial glucose and insulin | 30 adults without diabetes | Randomized, crossover, acute only |
| Allulose in type 2 diabetes | 10g cut glucose iAUC by 8% vs control | 24 adults with type 2 diabetes | Diagnosed population, single meal |
On exercise: a 13-month randomized trial in 54 early postmenopausal women with low bone density found the high-intensity group gained lean body mass while the control group lost it, and lost significantly more total and abdominal fat. Metabolic syndrome Z-score, though, did not differ significantly between groups (Hettchen et al., 2021). Body composition moved. The composite metabolic score didn't, at least not in 13 months.
In a separate 8-week trial in 45 postmenopausal women who already had metabolic syndrome, both resistance training and interval training lowered fasting blood sugar, HbA1c, waist circumference, and blood pressure (Kazemi et al., 2023). Those participants were a diagnosed population being monitored, which is exactly why that result sits in this section and not next to a product pitch.
What actually helps, ranked by how much it moves
Ordered by effect size, not by how fun it is.
Protect sleep first. If night sweats are wrecking your nights, that's a conversation with a doctor, not a supplement problem. Cooling the room, cutting evening alcohol, and a consistent wake time are cheap and they compound.
Build muscle. Skeletal muscle is the biggest destination for glucose in your body. More of it means more places for blood sugar to go. Two or three sessions a week of real resistance training, progressively loaded, beats an hour of steady cardio for this specific job.
Restructure meals, don't shrink them. Protein and fiber first, carbohydrate last. Same food, different order, flatter curve. Our guide to the best fiber for appetite control breaks down which types actually slow things down.
Walk after dinner. Ten to fifteen minutes. Unglamorous, well supported, and it directly targets the post-meal window where the damage happens.
Then look at what's in your glass. This is where a product like ours fits, and it fits fourth, not first.
Nothing you drink outranks sleep and muscle. Anything that tells you otherwise is selling harder than the evidence allows.
Where does Ozzi fit into this?
Honestly? In the supporting cast.
Ozzi is a drink stick you mix into 16oz of water. Its job is the craving window, not your endocrine system. Here's what's in it that's relevant to this conversation, and what the evidence behind each one actually is.
Allulose, 8g. A rare sugar that tastes sweet but is metabolized differently. In a randomized double-blind crossover study in 30 adults without diabetes, allulose taken with a 50g sucrose load produced dose-dependent reductions in plasma glucose and insulin, significant at the 10g dose (Franchi et al., 2021). A separate randomized crossover in 30 healthy Thai volunteers found the same dose-dependent pattern for peak postprandial glucose and insulin (Buranapin et al., 2024). These are single-meal studies, not long-term trials. We cover the nuance in does allulose spike blood sugar.
Glucomannan, 500mg. A viscous konjac fiber that absorbs water and expands in the stomach, which promotes fullness. Its lane is satiety and viscosity. We don't make gut barrier claims for it, because that evidence doesn't exist.
Chicory root inulin, 500mg. A prebiotic fiber that feeds butyrate-producing bacteria in the colon.
L-Lysine butyrate (BIOMEnd), 500mg. Butyrate is a short-chain fatty acid and the primary energy source for the cells lining your colon. The proposed link between butyrate and GLP-1 signaling comes from rodent and cell studies. No human trial has shown that supplemental butyrate raises GLP-1, and we're not going to imply one has.
Chromium as Metabolex, 11mg. Chromium is an essential trace mineral involved in insulin signaling. More on the actual evidence in chromium for cravings and blood sugar.
Ozzi supports natural GLP-1 production and supports blood sugar control. It does not treat, reverse, or cure insulin resistance, and if you're managing pre-diabetes you should be doing that with a doctor. Our post on pre-diabetes and GLP-1 goes deeper there.
The 9pm part is the part we can help with
Ozzi Crave Crusher is 8g of allulose, 500mg of butyrate, and 1g of fiber in a watermelon stick you mix into water. Take it for 14 days straight. If your cravings and food noise aren't quieter, we'll refund your first bag.
Frequently asked questions
Can you have insulin resistance with normal blood sugar?
Yes, and it's common. Your pancreas compensates by producing more insulin, which keeps glucose in range for years. Fasting insulin and HOMA-IR catch it earlier than fasting glucose does.
At what age does perimenopausal insulin resistance usually start?
There's no single switch. Perimenopause typically spans the mid-forties to early fifties, and metabolic changes often begin during that window rather than after periods stop.
Does insulin resistance cause weight gain, or the other way around?
Both directions run at once. Visceral fat worsens insulin signaling, and higher insulin makes fat storage easier. That's why it feels like a loop, because structurally it is one.
Which test should I ask for?
Fasting insulin alongside fasting glucose lets a clinician calculate HOMA-IR. HbA1c and a lipid panel add context. This is a conversation to have with your doctor, not something to self-diagnose from a blog.
Will hormone therapy help my metabolism?
Reviews report that estrogen therapy partly blunts the shift toward abdominal fat and is associated with improved insulin sensitivity, but it's prescribed for symptoms and bone health, not as a metabolic drug. That decision belongs with your physician.
Do I have to cut carbohydrates?
Not necessarily. Sequencing and fiber content usually matter more than elimination. Protein and vegetables before starch flattens the same meal's curve.
Why are my cravings so much worse at night?
Post-meal glucose drops, disrupted sleep, and a full day of decision fatigue all land in the same window. We wrote a whole piece on why sugar cravings spike at night.
Does allulose raise insulin?
Human crossover studies found the opposite pattern: adding allulose to a sugar load lowered postprandial glucose and insulin in a dose-dependent way. Those were acute, single-meal studies.
Is this the same thing that happens with PCOS?
The mechanisms overlap but the timeline and hormone drivers differ. See PCOS cravings and insulin resistance for that version.
Can a supplement fix insulin resistance?
No. Supplements can support blood sugar control and help with cravings. Sleep, muscle mass, and meal structure are the levers that actually move insulin sensitivity.
The part worth remembering
Nothing about you got weaker. The hormonal environment your habits were tuned to changed, and the habits stayed the same.
That's fixable, mostly with unglamorous things. Sleep you protect. Muscle you build slowly. Meals you reorder without shrinking. And a craving window you stop white-knuckling.
If you want the hormone side of the story, start with perimenopause appetite changes and estrogen and appetite. For the gut side, menopause and the gut microbiome covers what shifts down there. And if the underlying hormone is new to you, what is GLP-1 is the place to start.
References
- Davis SR, et al. Understanding weight gain at menopause. Climacteric. 2012. https://doi.org/10.3109/13697137.2012.707385
- Lambrinoudaki I, Armeni E. Understanding of and clinical approach to cardiometabolic transition at the menopause. Climacteric. 2023. https://doi.org/10.1080/13697137.2023.2202809
- El Khoudary SR, Nasr A. Cardiovascular disease in women: does menopause matter? Curr Opin Endocr Metab Res. 2022. https://doi.org/10.1016/j.coemr.2022.100419
- Janssen I, et al. Testosterone and visceral fat in midlife women: the SWAN fat patterning study. Obesity. 2010. https://doi.org/10.1038/oby.2009.251
- Chedraui P, Pérez-López FR. Metabolic syndrome during female midlife: what are the risks? Climacteric. 2019. https://doi.org/10.1080/13697137.2018.1561666
- Cybulska AM, et al. Diagnostic markers of insulin resistance to discriminate between prediabetes and diabetes in menopausal women. Eur Rev Med Pharmacol Sci. 2023. https://doi.org/10.26355/eurrev_202303_31779
- Zannas AS, et al. IL-6 response to psychosocial stress predicts 12-month changes in cardiometabolic biomarkers in perimenopausal women. J Clin Endocrinol Metab. 2020. https://doi.org/10.1210/clinem/dgaa476
- Broussard JL, et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction. Ann Intern Med. 2012. https://doi.org/10.7326/0003-4819-157-8-201210160-00005
- Hettchen M, et al. Changes in menopausal risk factors in early postmenopausal osteopenic women after 13 months of high-intensity exercise: the ACTLIFE-RCT. Clin Interv Aging. 2021. https://doi.org/10.2147/CIA.S283177
- Kazemi SS, et al. Effect of resistance training and high-intensity interval training on metabolic parameters in postmenopausal women with metabolic syndrome. Lipids Health Dis. 2023. https://doi.org/10.1186/s12944-023-01940-x
- Franchi F, et al. Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load. BMJ Open Diabetes Res Care. 2021. https://doi.org/10.1136/bmjdrc-2020-001939
- Buranapin S, et al. Effects of D-allulose with sucrose beverage on glucose tolerance and insulin levels among Thai healthy volunteers. J Nutr Sci Vitaminol. 2024. https://doi.org/10.3177/jnsv.70.203
- Noronha JC, et al. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes. Diabetes Obes Metab. 2018. https://doi.org/10.1111/dom.13374
Citations retrieved via PubMed. This article is for education and is not medical advice. Talk to your doctor about testing or treating insulin resistance.
